Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T00176 | Target Info | |||
Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | ||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Target Type | Clinical trial Target | ||||
Gene Name | MDM2 | ||||
Biochemical Class | Acyltransferase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 4 Acid anhydride hydrolases | + | |||
Interacting Protein Name | X-ray repair cross-complementing protein 6 (XRCC6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CTC75; CTCBF; G22P1; KU70; ML8; TLAA | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Biochemical Activity | [2] | |||
4 | Reconstituted Complex | [2] | |||
Interacting Protein Name | Elongation factor 1-alpha 1 (EEF1A1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCS.3; CCS3; EE1A1; EEF.1; EEF1A; EF.Tu; EF1A; GRAF.1EF; HNGC:16303; LENG7; PTI1; eEF1A.1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Reconstituted Complex | [4] | |||
Interacting Protein Name | Guanine nucleotide-binding protein-like 3 (GNL3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C77032; E2IG3; NNP47; NS | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Reconstituted Complex | [6] | |||
Interacting Protein Name | Proteasome 26S subunit ATPase 3 (PSMC3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TBP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Co-fractionation | [8] | |||
Acyltransferases | [+] 9 Acyltransferases | + | |||
Interacting Target Name | X-linked inhibitor of apoptosis protein (XIAP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | X-linked IAP; Xlinked IAP; RING-type E3 ubiquitin transferase XIAP; Inhibitor of apoptosis protein 3; ILP; IAP-like protein; IAPlike protein; IAP-3; IAP3; hILP; hIAP-3; hIAP3; E3 ubiquitin-protein ligase XIAP; E3 ubiquitinprotein ligase XIAP; BIRC4; Baculoviral IAP repeat-containing protein 4; Baculoviral IAP repeatcontaining protein 4; API3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Protein-peptide | [10] | |||
3 | Reconstituted Complex | [11] | |||
Interacting Target Name | Histone acetyltransferase KAT2B (KAT2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spermidine acetyltransferase KAT2B; PCAF; P300/CBP-associated factor; P/CAF; Lysine acetyltransferase 2B; Histone acetyltransferase PCAF; Histone acetylase PCAF | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Biochemical Activity | [12] | |||
3 | Reconstituted Complex | [13] | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Co-fractionation | [15] | |||
3 | Reconstituted Complex | [14] | |||
Interacting Target Name | Transcription intermediary factor 1-beta (TRIM28) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tripartite motif-containing protein 28; TIF1-beta; TIF1B; RNF96; RING-type E3 ubiquitin transferase TIF1-beta; RING finger protein 96; Nuclear corepressor KAP-1; KRIP-1; KRAB-interacting protein 1; KRAB-associated protein 1; KAP-1; KAP1; E3 SUMO-protein ligase TRIM28 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [16] | |||
2 | Affinity Capture-Western | [16] | |||
Interacting Protein Name | Histone acetyltransferase KAT5 (KAT5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Reconstituted Complex | [18] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase RBBP6 (RBBP6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P2P.R; PACT; RBQ.1; SNAMA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Biochemical Activity | [20] | |||
Interacting Protein Name | Transcription initiation factor TFIID subunit 1 (TAF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BA2R; CCG1; CCGS; DYT3; DYT3/TAF1; KAT4; N.TAF1; NSCL2; OF; P250; TAF(II)250; TAF2A; TAFII.250; TAFII250; XDP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Reconstituted Complex | [22] | |||
Interacting Protein Name | NEDD8-conjugating enzyme Ubc12 (UBE2M) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UBC.RS2; UBC12; hUbc12 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Reconstituted Complex | [24] | |||
Interacting Protein Name | RING finger and CHY zinc finger domain-containing protein 1 (RCHY1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARNIP; CHIMP; PIRH2; PRO1996; RNF199; ZCHY; ZNF363 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Reconstituted Complex | [26] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Co-localization | [28] | |||
3 | Reconstituted Complex | [27] | |||
Cell cycle related proteins | [+] 1 Cell cycle related proteins | + | |||
Interacting Target Name | Multiple tumor suppressor 1 (CDKN2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour suppressor gene p16; P16-INK4a; p16INK4A; P16-INK4; P16 gene; MTS-1; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [29] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Fluorescence Resonance Energy Transfer | [31] | |||
4 | Protein-peptide | [32] | |||
5 | Reconstituted Complex | [30] | |||
Heat shock proteins | [+] 3 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [33] | |||
3 | Co-purification | [34] | |||
4 | Protein-peptide | [35] | |||
5 | Reconstituted Complex | [34] | |||
Interacting Target Name | Endoplasmin (HSP90B1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor rejection antigen 1; TRA1; Heat shock protein 90 kDa beta member 1; GRP-94; GRP94; gp96 homolog; 94 kDa glucose-regulated protein; 94 kDa glucoseregulated protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Reconstituted Complex | [37] | |||
Interacting Target Name | Lipopolysaccharide-associated protein 1 (HSPA8) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LPS-associated protein 1; LAP-1; HSPA10; HSP73; HSC70; Heat shock protein 73; Heat shock cognate 71 kDa protein; Heat shock 70 kDa protein 8 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [33] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | DNA topoisomerase I (TOP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DNA topoisomerase I | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Protein-peptide | [38] | |||
Kinases | [+] 12 Kinases | + | |||
Interacting Target Name | Tyrosine-protein kinase ABL1 (ABL) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; p150; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Biochemical Activity | [39] | |||
3 | Protein-peptide | [23] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Biochemical Activity | [41] | |||
3 | Co-localization | [42] | |||
Interacting Target Name | Telomerase reverse transcriptase (TERT) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRT; TP2; Telomerase-associated protein 2; Telomerase catalytic subunit; TCS1; HEST2; EST2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [43] | |||
2 | Biochemical Activity | [43] | |||
3 | Reconstituted Complex | [43] | |||
Interacting Target Name | Insulin-like growth factor I receptor (IGF1R) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Biochemical Activity | [45] | |||
Interacting Target Name | Serine/threonine-protein kinase Chk2 (RAD53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Hucds1; hCds1; CHK2 checkpoint homolog; CHK2; Checkpoint kinase 2; Cds1 homolog; Cds1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [46] | |||
2 | Reconstituted Complex | [47] | |||
Interacting Target Name | Serine/threonine-protein kinase pim-1 (PIM1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PIM; Pim-1 proto-oncogene, serine/threonine kinase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [48] | |||
2 | Biochemical Activity | [49] | |||
Interacting Target Name | Beta-adrenergic receptor kinase 1 (ADRBK1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GRK2; G-protein coupled receptor kinase 2; Beta-ARK-1; BetaARK1; Beta ARK1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [50] | |||
2 | Affinity Capture-Western | [51] | |||
Interacting Target Name | Death-associated protein kinase 3 (DAPK3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Zipper-interacting protein kinase; ZIP-kinase; ZIPK; MYPT1 kinase; Dlk; DAP-like kinase; DAP kinase 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [35] | |||
2 | Co-localization | [52] | |||
Interacting Target Name | Casein kinase I delta (CSNK1D) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tau-protein kinase CSNK1D; HCKID; CKI-delta; CKId; Casein kinase I isoform delta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [53] | |||
2 | Biochemical Activity | [54] | |||
Interacting Target Name | Homeodomain interacting protein kinase 2 (HIPK2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Homeodomain-interacting protein kinase 2; hHIPk2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [55] | |||
2 | Biochemical Activity | [56] | |||
Interacting Protein Name | Serine/threonine-protein kinase PAK 6 (PAK6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PAK5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [57] | |||
2 | Affinity Capture-Western | [58] | |||
Interacting Target Name | Pyruvate kinase M2 (PKM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor M2-PK; Thyroid hormone-binding protein 1; THBP1; Pyruvate kinase PKM; Pyruvate kinase muscle isozyme; Pyruvate kinase isozymes M1/M2; Pyruvate kinase 2/3; PKM2; PK3; PK2; p58; Opa-interacting protein 3; OIP-3; OIP3; Cytosolic thyroid hormone-binding protein; CTHBP | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Reconstituted Complex | [37] | |||
Nuclear hormone receptors | [+] 3 Nuclear hormone receptors | + | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [58] | |||
2 | Biochemical Activity | [59] | |||
3 | Co-localization | [28] | |||
4 | Reconstituted Complex | [60] | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [61] | |||
2 | Reconstituted Complex | [61] | |||
3 | Yeast two hybrid | [62] | |||
Interacting Target Name | Orphan nuclear receptor SHP (NR0B2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Small heterodimer partner; SHP; Short heterodimer partner; Nuclear receptor subfamily 0 group B member 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [63] | |||
2 | Co-localization | [64] | |||
Peptidases | [+] 3 Peptidases | + | |||
Interacting Target Name | Herpesvirus ubiquitin-specific protease (HAUSP) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 7; Ubiquitin thioesterase 7; Ubiquitin carboxyl-terminal hydrolase 7; Herpesvirus-associated ubiquitin-specific protease; Deubiquitinating enzyme 7 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [57] | |||
2 | Affinity Capture-Western | [65] | |||
3 | Co-crystal Structure | [66] | |||
4 | Co-fractionation | [67] | |||
5 | Protein-peptide | [67] | |||
6 | Reconstituted Complex | [68] | |||
Interacting Target Name | Caspase-3 (CASP3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Yama protein; SREBP cleavage activity 1; SCA-1; Protein Yama; Cysteine protease CPP32; CPP-32; CPP32; Caspase 3; CASP-3; Apopain | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [69] | |||
2 | Co-localization | [42] | |||
Interacting Protein Name | Proteasome subunit alpha type-7 (PSMA7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C6; HSPC; RC6.1; XAPC7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [70] | |||
2 | Co-fractionation | [8] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [71] | |||
2 | Biochemical Activity | [72] | |||
3 | Co-crystal Structure | [73] | |||
4 | Co-fractionation | [14] | |||
5 | Protein-Fragment Complementation Assay | [74] | |||
6 | Reconstituted Complex | [71] | |||
Proteasome components | [+] 1 Proteasome components | + | |||
Interacting Protein Name | Proteasome 26S subunit non-ATPase 4 (PSMD4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF; AF.1; ASF; MCB1; Rpn10; S5A; pUB.R5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Biochemical Activity | [75] | |||
Proteins 14-3-3 | [+] 2 Proteins 14-3-3 | + | |||
Interacting Protein Name | 14-3-3 protein sigma (SFN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | YWHAS | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [76] | |||
2 | Reconstituted Complex | [76] | |||
Interacting Protein Name | 14-3-3 protein theta (YWHAQ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3; 1C5; HS1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [77] | |||
2 | Reconstituted Complex | [78] | |||
Ribosomal proteins | [+] 6 Ribosomal proteins | + | |||
Interacting Protein Name | Large ribosomal subunit protein uL5 (RPL11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA7; GIG34; L11 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [79] | |||
2 | Affinity Capture-Western | [80] | |||
3 | Co-fractionation | [81] | |||
4 | Co-purification | [82] | |||
5 | Reconstituted Complex | [83] | |||
6 | Yeast two hybrid | [84] | |||
Interacting Protein Name | Large ribosomal subunit protein uL24 (RPL26) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA11; L26 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [85] | |||
2 | Biochemical Activity | [86] | |||
3 | Co-localization | [85] | |||
4 | Reconstituted Complex | [85] | |||
5 | Yeast two hybrid | [85] | |||
Interacting Protein Name | Large ribosomal subunit protein uL14 (RPL23) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | L23; rpL17 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [79] | |||
2 | Affinity Capture-Western | [87] | |||
3 | Co-fractionation | [88] | |||
4 | Reconstituted Complex | [88] | |||
Interacting Protein Name | Large ribosomal subunit protein uL18 (RPL5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA6; L5; PPP1R135 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [79] | |||
2 | Affinity Capture-Western | [89] | |||
3 | Co-fractionation | [81] | |||
4 | Reconstituted Complex | [83] | |||
Interacting Protein Name | Small ribosomal subunit protein eS7 (RPS7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA8; S7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [90] | |||
2 | Reconstituted Complex | [90] | |||
3 | Yeast two hybrid | [90] | |||
Interacting Protein Name | Small ribosomal subunit protein uS10 (RPS20) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | S20 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [91] | |||
Transcription regulators | [+] 14 Transcription regulators | + | |||
Interacting Target Name | Interferon regulatory factor 1 (IRF1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRF-1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [92] | |||
2 | Biochemical Activity | [93] | |||
3 | Protein-peptide | [38] | |||
4 | Reconstituted Complex | [93] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [94] | |||
2 | Biochemical Activity | [95] | |||
3 | Reconstituted Complex | [96] | |||
Interacting Protein Name | Tumor protein p73 (TP73) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P73 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [97] | |||
2 | Biochemical Activity | [98] | |||
3 | Reconstituted Complex | [99] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [100] | |||
2 | Reconstituted Complex | [100] | |||
3 | Yeast two hybrid | [84] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [101] | |||
2 | Biochemical Activity | [102] | |||
Interacting Target Name | Notch-1 receptor (NOTCH1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Translocation-associated notch protein TAN-1; Translocationassociated notch protein TAN1; TAN1; Notch 1 intracellular domain; Notch 1; NICD; Neurogenic locus notch homolog protein 1; hN1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [103] | |||
2 | Biochemical Activity | [104] | |||
Interacting Target Name | E2F transcription factor 1 (E2F1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor E2F1; Retinoblastoma-binding protein 3; Retinoblastoma-associated protein 1; RBBP-3; RBBP3; RBAP-1; pRB-binding protein E2F-1; PBR3; E2F-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [105] | |||
2 | Biochemical Activity | [106] | |||
Interacting Target Name | Activating transcription factor 4 (ATF-4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TXREB; Tax-responsive enhancer element-binding protein 67; Taxresponsive enhancer elementbinding protein 67; TaxREB67; DNA-binding protein TAXREB67; DNAbinding protein TAXREB67; Cyclic AMP-responsive element-binding protein 2; Cyclic AMPresponsive elementbinding protein 2; Cyclic AMP-dependent transcription factor ATF-4; Cyclic AMPdependent transcription factor ATF4; CREB-2; CREB2; cAMP-responsive element-binding protein 2; cAMPresponsive elementbinding protein 2; cAMP-dependent transcription factor ATF-4; cAMPdependent transcription factor ATF4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [107] | |||
2 | Yeast two hybrid | [84] | |||
Interacting Target Name | Cyclic-AMP-dependent transcription factor ATF-3 (ATF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-dependent transcription factor ATF-3; cAMP-dependent transcription factor ATF-3; Activating transcription factor 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [108] | |||
2 | Reconstituted Complex | [108] | |||
Interacting Protein Name | Forkhead box protein O4 (FOXO4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AFX; AFX1; MLLT7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [109] | |||
2 | Biochemical Activity | [109] | |||
Interacting Protein Name | General transcription factor II-I (GTF2I) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BAP135; BTKAP1; DIWS; GTFII.I; IB291; SPIN; TFII.I; WBS; WBSCR6 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [110] | |||
Interacting Protein Name | Interferon regulatory factor 2 (IRF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRF.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [111] | |||
2 | Protein-peptide | [38] | |||
Interacting Protein Name | Tumor protein 63 (TP63) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [112] | |||
2 | Reconstituted Complex | [113] | |||
Interacting Protein Name | Forkhead box protein O3 (FOXO3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [114] | |||
Ubiquitin related proteins | [+] 4 Ubiquitin related proteins | + | |||
Interacting Protein Name | Ubiquitin-40S ribosomal protein S27a (RPS27A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CEP80; HEL112; S27A; UBA80; UBC; UBCEP1; UBCEP80 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [115] | |||
2 | Biochemical Activity | [115] | |||
3 | Yeast two hybrid | [84] | |||
Interacting Protein Name | Ubiquitin conjugation factor E4 B (UBE4B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E4; HDNB1; UBOX3; UFD2; UFD2A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [116] | |||
2 | Co-fractionation | [117] | |||
3 | Reconstituted Complex | [117] | |||
Interacting Target Name | Polyubiquitin-C (UBC) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG20; ubiquitin C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [118] | |||
2 | Reconstituted Complex | [119] | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 D2 (UBE2D2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2(17)KB2; PUBC1; UBC4; UBC4/5; UBCH4; UBCH5B | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [120] | |||
2 | Reconstituted Complex | [121] | |||
Other proteins | [+] 15 Other proteins | + | |||
Interacting Target Name | p53-binding protein Mdm4 (MDM4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein Mdmx; p53-binding protein Mdm4; Mdm2-like p53-binding protein; Double minute 4 protein | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [57] | |||
2 | Affinity Capture-Western | [122] | |||
3 | Co-crystal Structure | [123] | |||
4 | Protein-peptide | [124] | |||
5 | Reconstituted Complex | [125] | |||
6 | Yeast two hybrid | [84] | |||
Interacting Target Name | Beta-arrestin-2 (ARRB2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Non-visual arrestin-3; Betaarrestin2; Arrestin beta-2; Arrestin beta2; ARR2; ARB2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [126] | |||
2 | Biochemical Activity | [127] | |||
3 | Co-localization | [128] | |||
4 | Yeast two hybrid | [127] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [129] | |||
3 | Fluorescence Resonance Energy Transfer | [130] | |||
4 | Reconstituted Complex | [129] | |||
Interacting Protein Name | Protein numb homolog (NUMB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C14orf41; S171; c14_5527 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [71] | |||
2 | Biochemical Activity | [131] | |||
3 | Reconstituted Complex | [131] | |||
4 | Yeast two hybrid | [132] | |||
Interacting Target Name | Nucleolin (NCL) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein C23; Nucleolin | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [133] | |||
3 | Reconstituted Complex | [37] | |||
Interacting Protein Name | Mdm2-binding protein (MTBP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MDM2BP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [134] | |||
2 | Reconstituted Complex | [134] | |||
3 | Yeast two hybrid | [134] | |||
Interacting Target Name | Nucleophosmin (NPM1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Numatrin; Nucleolar protein NO38; Nucleolar phosphoprotein B23; NPM | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [135] | |||
2 | Reconstituted Complex | [136] | |||
Interacting Target Name | Beta-arrestin-1 (ARRB1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Non-visual arrestin-2; Betaarrestin1; Arrestin beta-1; Arrestin beta1; ARR1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [137] | |||
2 | Yeast two hybrid | [127] | |||
Interacting Target Name | Epithelial cadherin (CDH1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Uvomorulin; UVO; E-cadherin gene; E-cadherin; CDHE; CD324; CAM 120/80; Cadherin-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [138] | |||
2 | Reconstituted Complex | [138] | |||
Interacting Target Name | Gankyrin (PSMD10) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p28(GANK); 26S proteasome regulatory subunit p28; 26S proteasome non-ATPase regulatory subunit 10 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [119] | |||
2 | Reconstituted Complex | [139] | |||
Interacting Protein Name | Nibrin (NBN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AT.V1; AT.V2; ATV; NBS; NBS1; P95 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [140] | |||
2 | Affinity Capture-Western | [140] | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [141] | |||
2 | Reconstituted Complex | [142] | |||
Interacting Protein Name | Small integral membrane protein 40 (SMIM40) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BING2; DAP6; EAP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [143] | |||
2 | Reconstituted Complex | [144] | |||
Interacting Protein Name | Polycomb protein SUZ12 (SUZ12) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CHET9; JJAZ1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [57] | |||
2 | Affinity Capture-Western | [145] | |||
Interacting Protein Name | Nucleolar transcription factor 1 (UBTF) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NOR.90; UBF; UBF.1; UBF1; UBF2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [20] | |||
2 | Protein-peptide | [38] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator. PLoS One. 2013 Oct 11;8(10):e77643. | ||||
REF 2 | Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization. Cell Death Differ. 2009 May;16(5):758-69. | ||||
REF 3 | HDM2-binding partners: interaction with translation elongation factor EF1alpha. J Proteome Res. 2007 Apr;6(4):1410-7. | ||||
REF 4 | Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell. 2012 Dec 21;151(7):1581-94. | ||||
REF 5 | Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF. Oncogene. 2015 Mar 26;34(13):1688-97. | ||||
REF 6 | Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci. 2008 Dec 15;121(Pt 24):4037-46. | ||||
REF 7 | Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability. FEBS Lett. 2012 Jul 30;586(16):2225-31. | ||||
REF 8 | Mdm2 facilitates the association of p53 with the proteasome. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10038-43. | ||||
REF 9 | XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J. 2013 Aug 14;32(16):2204-16. | ||||
REF 10 | Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival. Mol Cancer. 2015 Mar 26;14:65. | ||||
REF 11 | Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell. 2009 May 5;15(5):363-75. | ||||
REF 12 | MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation. J Biol Chem. 2004 May 7;279(19):20035-43. | ||||
REF 13 | MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem. 2002 Aug 23;277(34):30838-43. | ||||
REF 14 | p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell. 1998 Oct;2(4):405-15. | ||||
REF 15 | MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12547-52. | ||||
REF 16 | MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 2005 Sep 21;24(18):3279-90. | ||||
REF 17 | Specific inhibition of Mdm2-mediated neddylation by Tip60. Cell Cycle. 2008 Jan 15;7(2):222-31. | ||||
REF 18 | Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 2002 Apr 2;21(7):1704-12. | ||||
REF 19 | PACT is a negative regulator of p53 and essential for cell growth and embryonic development. Proc Natl Acad Sci U S A. 2007 May 8;104(19):7951-6. | ||||
REF 20 | Screening E3 substrates using a live phage display library. PLoS One. 2013 Oct 4;8(10):e76622. | ||||
REF 21 | Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53. Oncogene. 2007 Jun 21;26(29):4234-42. | ||||
REF 22 | The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. J Biol Chem. 1997 Dec 5;272(49):30651-61. | ||||
REF 23 | Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1749-54. | ||||
REF 24 | Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell. 2004 Jul 9;118(1):83-97. | ||||
REF 25 | Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep. 2011 Jan;38(1):229-36. | ||||
REF 26 | Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains. J Biol Chem. 2009 Aug 14;284(33):21955-70. | ||||
REF 27 | MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 2002 Nov 15;21(22):6236-45. | ||||
REF 28 | Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005 Jan 7;33(1):13-26. | ||||
REF 29 | Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003 Dec;23(23):8902-12. | ||||
REF 30 | Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Oncogene. 2002 Jul 4;21(29):4498-507. | ||||
REF 31 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 32 | An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene. 2000 May 4;19(19):2312-23. | ||||
REF 33 | Hispolon promotes MDM2 downregulation through chaperone-mediated autophagy. Biochem Biophys Res Commun. 2010 Jul 16;398(1):26-31. | ||||
REF 34 | Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein. J Mol Biol. 2004 Mar 12;337(1):129-45. | ||||
REF 35 | Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1. J Mol Biol. 2004 Mar 12;337(1):115-28. | ||||
REF 36 | Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer. Cancer Lett. 2015 Apr 10;359(2):325-34. | ||||
REF 37 | A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One. 2010 Feb 24;5(2):e9289. | ||||
REF 38 | A systems wide mass spectrometric based linear motif screen to identify dominant in-vivo interacting proteins for the ubiquitin ligase MDM2. Cell Signal. 2014 Jun;26(6):1243-57. | ||||
REF 39 | Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J. 2002 Jul 15;21(14):3715-27. | ||||
REF 40 | HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol. 2001 Nov;3(11):973-82. | ||||
REF 41 | Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 2002 Jun 14;277(24):21843-50. | ||||
REF 42 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 43 | Hdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERT. Oncogene. 2010 Jul 15;29(28):4101-12. | ||||
REF 44 | Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52. | ||||
REF 45 | Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res. 2008 Jul 15;68(14):5669-77. | ||||
REF 46 | Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities. Cell Cycle. 2009 Feb 1;8(3):430-7. | ||||
REF 47 | HDM2 negatively affects the Chk2-mediated phosphorylation of p53. FEBS Lett. 2005 May 9;579(12):2604-8. | ||||
REF 48 | Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma. J Biol Chem. 2008 Jun 27;283(26):18012-23. | ||||
REF 49 | 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2--Potential interplay with the PKB/Akt pathway and p14(ARF). FEBS Lett. 2009 Feb 18;583(4):615-20. | ||||
REF 50 | The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization. Glia. 2015 Dec;63(12):2327-39. | ||||
REF 51 | Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2. J Biol Chem. 2011 Jan 14;286(2):1165-73. | ||||
REF 52 | Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly. Oncogene. 2013 Oct 10;32(41):4981-8. | ||||
REF 53 | DNA damage-induced activation of ATM promotes -TRCP-mediated Mdm2 ubiquitination and destruction. Oncotarget. 2012 Sep;3(9):1026-35. | ||||
REF 54 | Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell. 2010 Aug 9;18(2):147-59. | ||||
REF 55 | HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett. 2005 Oct 24;579(25):5473-80. | ||||
REF 56 | MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell. 2007 Mar 9;25(5):739-50. | ||||
REF 57 | Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. EMBO Rep. 2018 Feb;19(2):305-319. | ||||
REF 58 | p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J Biol Chem. 2013 Feb 1;288(5):3359-69. | ||||
REF 59 | The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J. 2011 Feb 2;30(3):468-79. | ||||
REF 60 | Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002 Aug 1;21(15):4037-48. | ||||
REF 61 | Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res. 2007 Jun 1;67(11):5513-21. | ||||
REF 62 | MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem Biophys Res Commun. 2001 Feb 16;281(1):259-65. | ||||
REF 63 | An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stability. FEBS Lett. 2012 Apr 24;586(8):1135-40. | ||||
REF 64 | Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition. Biochem Biophys Res Commun. 2012 Jan 13;417(2):744-6. | ||||
REF 65 | USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep. 2016 Mar 22;14(11):2528-37. | ||||
REF 66 | Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol. 2006 Mar;13(3):285-91. | ||||
REF 67 | Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 2006 Feb;4(2):e27. | ||||
REF 68 | Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7. J Mol Biol. 2010 Oct 8;402(5):825-37. | ||||
REF 69 | A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells. Oncogene. 1998 Nov 19;17(20):2629-36. | ||||
REF 70 | MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell. 2005 Dec 9;20(5):699-708. | ||||
REF 71 | NUMB controls p53 tumour suppressor activity. Nature. 2008 Jan 3;451(7174):76-80. | ||||
REF 72 | Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science. 2003 Dec 12;302(5652):1972-5. | ||||
REF 73 | Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996 Nov 8;274(5289):948-53. | ||||
REF 74 | Reverse MAPPIT: screening for protein-protein interaction modifiers in mammalian cells. Nat Methods. 2005 Jun;2(6):427-33. | ||||
REF 75 | The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition. J Biol Chem. 2009 May 8;284(19):12622-32. | ||||
REF 76 | Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene. 2007 Nov 15;26(52):7355-62. | ||||
REF 77 | Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. Mol Cell Biol. 2006 Sep;26(18):6819-31. | ||||
REF 78 | 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol Cell Biol. 2010 Mar;30(6):1508-27. | ||||
REF 79 | MDMX regulation of p53 response to ribosomal stress. EMBO J. 2006 Nov 29;25(23):5614-25. | ||||
REF 80 | PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop. Nucleic Acids Res. 2011 Mar;39(6):2234-48. | ||||
REF 81 | 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem. 2007 Mar 16;282(11):8052-9. | ||||
REF 82 | Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation. J Biol Chem. 2011 Nov 4;286(44):38264-74. | ||||
REF 83 | Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem. 2004 Oct 22;279(43):44475-82. | ||||
REF 84 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 85 | Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res. 2010 Oct;38(19):6544-54. | ||||
REF 86 | Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell. 2008 Oct 24;32(2):180-9. | ||||
REF 87 | Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20467-72. | ||||
REF 88 | Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol. 2004 Sep;24(17):7654-68. | ||||
REF 89 | The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol. 1994 Nov;14(11):7414-20. | ||||
REF 90 | Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007 Aug 2;26(35):5029-37. | ||||
REF 91 | Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One. 2013 Jul 16;8(7):e68667. | ||||
REF 92 | Fungal engagement of the C-type lectin mincle suppresses dectin-1-induced antifungal immunity. Cell Host Microbe. 2014 Apr 9;15(4):494-505. | ||||
REF 93 | DNA-binding regulates site-specific ubiquitination of IRF-1. Biochem J. 2013 Feb 1;449(3):707-17. | ||||
REF 94 | Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1 stabilization/nuclear translocation in bone metastasis from breast carcinoma. Exp Cell Res. 2015 Jan 15;330(2):287-99. | ||||
REF 95 | Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000 Jan 1;14(1):34-44. | ||||
REF 96 | Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003 Apr 18;278(16):13595-8. | ||||
REF 97 | TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex. J Biol Chem. 2008 Jul 18;283(29):20077-86. | ||||
REF 98 | MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function. Oncotarget. 2015 Aug 28;6(25):21479-92. | ||||
REF 99 | MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol. 1999 May;19(5):3257-66. | ||||
REF 100 | A novel mechanism of crosstalk between the p53 and NFB pathways: MDM2 binds and inhibits p65RelA. Cell Cycle. 2013 Aug 1;12(15):2479-92. | ||||
REF 101 | Coordinate regulation of estrogen receptor degradation by Mdm2 and CREB-binding protein in response to growth signals. Oncogene. 2013 Jan 3;32(1):117-26. | ||||
REF 102 | Inhibition of p53 degradation by Mdm2 acetylation. FEBS Lett. 2004 Mar 12;561(1-3):195-201. | ||||
REF 103 | Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol. 2011 Nov 30;9:83. | ||||
REF 104 | Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway. Biochem J. 2013 Mar 15;450(3):523-36. | ||||
REF 105 | Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway. Oncogene. 2005 Nov 3;24(48):7238-47. | ||||
REF 106 | ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1. FEBS J. 2008 Oct;275(19):4875-86. | ||||
REF 107 | Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53. Mol Cell. 2016 Jun 16;62(6):890-902. | ||||
REF 108 | MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem. 2010 Aug 27;285(35):26908-15. | ||||
REF 109 | Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase. Antioxid Redox Signal. 2011 Feb 15;14(4):563-78. | ||||
REF 110 | A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity. PLoS One. 2015 Dec 11;10(12):e0144753. | ||||
REF 111 | Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2. Biochem J. 2009 Mar 15;418(3):575-85. | ||||
REF 112 | MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J Cell Sci. 2010 Jul 15;123(Pt 14):2423-33. | ||||
REF 113 | Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Cell Cycle. 2010 Nov 15;9(22):4584-91. | ||||
REF 114 | MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem. 2009 May 22;284(21):13987-4000. | ||||
REF 115 | Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. J Biol Chem. 2011 Jul 1;286(26):22730-41. | ||||
REF 116 | Regulation of p53 level by UBE4B in breast cancer. PLoS One. 2014 Feb 26;9(2):e90154. | ||||
REF 117 | UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat Med. 2011 Mar;17(3):347-55. | ||||
REF 118 | OTUD5 regulates p53 stability by deubiquitinating p53. PLoS One. 2013 Oct 15;8(10):e77682. | ||||
REF 119 | The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell. 2005 Jul;8(1):75-87. | ||||
REF 120 | MDMX contains an autoinhibitory sequence element. Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17814-9. | ||||
REF 121 | Reciprocal repression between P53 and TCTP. Nat Med. 2011 Dec 11;18(1):91-9. | ||||
REF 122 | Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell. 2009 Aug 14;35(3):316-26. | ||||
REF 123 | Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 2008 May;15(5):841-8. | ||||
REF 124 | Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy. Cancer Res. 2015 Nov 1;75(21):4560-72. | ||||
REF 125 | HDMX folds the nascent p53 mRNA following activation by the ATM kinase. Mol Cell. 2014 May 8;54(3):500-11. | ||||
REF 126 | Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem. 2003 Feb 21;278(8):6363-70. | ||||
REF 127 | Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 2001 Nov 9;294(5545):1307-13. | ||||
REF 128 | Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of -arrestin2. Mol Biol Cell. 2011 May;22(9):1608-16. | ||||
REF 129 | MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem. 2004 Apr 16;279(16):16000-6. | ||||
REF 130 | MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change. J Biol Chem. 2010 Jun 11;285(24):18407-14. | ||||
REF 131 | Mammalian Numb is a target protein of Mdm2, ubiquitin ligase. Biochem Biophys Res Commun. 2003 Mar 21;302(4):869-72. | ||||
REF 132 | MDM2 interacts with and downregulates a sarcomeric protein, TCAP. Biochem Biophys Res Commun. 2006 Jun 23;345(1):355-61. | ||||
REF 133 | Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene. 2006 Nov 23;25(55):7274-88. | ||||
REF 134 | A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J Biol Chem. 2000 Oct 13;275(41):31883-90. | ||||
REF 135 | An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasis. J Proteome Res. 2012 Nov 2;11(11):5464-78. | ||||
REF 136 | Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 2004 May;5(5):465-75. | ||||
REF 137 | Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem. 2003 Mar 28;278(13):11648-53. | ||||
REF 138 | MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol. 2006 Oct;26(19):7269-82. | ||||
REF 139 | The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity. Biochem Biophys Res Commun. 2007 Nov 23;363(3):879-84. | ||||
REF 140 | Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair. J Biol Chem. 2005 May 13;280(19):18771-81. | ||||
REF 141 | BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene. 2013 Jun 27;32(26):3156-64. | ||||
REF 142 | Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci. 2003 Oct 1;116(Pt 19):3917-25. | ||||
REF 143 | p14ARF interacts with DAXX: effects on HDM2 and p53. Cell Cycle. 2008 Jun 15;7(12):1836-50. | ||||
REF 144 | Negative regulation of p53 functions by Daxx and the involvement of MDM2. J Biol Chem. 2004 Nov 26;279(48):50566-79. | ||||
REF 145 | MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53. Mol Cell. 2016 Jan 7;61(1):68-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.